Stockscreener 앱 받기
9.05
1.57%
0.14
전일 마감가:
$8.91
열려 있는:
$8.95
하루 거래량:
961.53K
Relative Volume:
0.42
시가총액:
$1.37B
수익:
$177.28M
순이익/손실:
$-195.24M
주가수익비율:
-6.7537
EPS:
-1.34
순현금흐름:
$-114.54M
1주 성능:
+0.22%
1개월 성능:
+20.83%
6개월 성능:
+78.15%
1년 성능:
+143.28%
1일 변동 폭
$8.8076
$9.119
1주일 범위
$8.77
$9.81
52주 변동 폭
$2.99
$10.28
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
명칭
Adaptive Biotechnologies Corp
전화
206-659-0067
주소
1165 EASTLAKE AVE E, SEATTLE, WA
ADPT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
9.05 | 1.37B | 177.28M | -195.24M | -114.54M | -1.34 |
|
ONC
Beigene Ltd Adr
|
228.38 | 25.07B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.65 | 109.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 36.39M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
594.32 | 56.98B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
71.31 | 5.39B | 0 | -153.72M | -103.81M | -2.00 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-12-21 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Underperform |
| 2022-06-03 | 개시 | Piper Sandler | Neutral |
| 2022-02-16 | 재확인 | BTIG Research | Buy |
| 2022-02-16 | 재확인 | BofA Securities | Buy |
| 2022-02-16 | 재확인 | Goldman | Neutral |
| 2022-02-16 | 재확인 | JP Morgan | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-03-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-08 | 재개 | BTIG Research | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-06-03 | 개시 | Goldman | Buy |
| 2019-07-23 | 개시 | BTIG Research | Buy |
| 2019-07-22 | 개시 | BofA/Merrill | Buy |
| 2019-07-22 | 개시 | Cowen | Outperform |
| 2019-07-22 | 개시 | Goldman | Neutral |
| 2019-07-22 | 개시 | Guggenheim | Buy |
| 2019-07-22 | 개시 | William Blair | Outperform |
모두보기
Adaptive Biotechnologies Corp 주식(ADPT)의 최신 뉴스
Jane Street Group LLC Sells 97,690 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Holdings Lowered by Price T Rowe Associates Inc. MD - Defense World
Does Adaptive Biotechnologies Corp (NASDAQ: ADPT) Still Look Hot This Week? - Stocksregister
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Purchased by Dimensional Fund Advisors LP - Defense World
Adaptive Biotechnologies (ADPT) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Does Adaptive Biotechnologies (ADPT) Have the Potential to Rally 26.45% as Wall Street Analysts Expect? - Yahoo Finance
Has Adaptive Biotechnologies (ADPT) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Brokerages Set Adaptive Biotechnologies Co. (NASDAQ:ADPT) Price Target at $9.50 - Defense World
Trading Day Review: Adaptive Biotechnologies Corp (ADPT) Loses Momentum, Closing at 8.81 - DWinneX
MetLife Investment Management LLC Acquires 3,650 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World
Adaptive Biotechnologies (ADPT) Price Target Raised by Piper San - GuruFocus
Adaptive Biotechnologies (ADPT) Price Target Raised by Piper Sandler | ADPT Stock News - GuruFocus
Adaptive Biotechnologies Reaches Analyst Target Price - Nasdaq
ADPT Price Target Increased to $13 by Piper Sandler | ADPT Stock News - GuruFocus
Adaptive Biotechnologies (NASDAQ:ADPT) Sees Unusually-High Trading Volume Following Analyst Upgrade - Defense World
Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $9.00 at Morgan Stanley - Defense World
Adaptive Biotechnologies (ADPT) Price Target Raised by Morgan St - GuruFocus
5 Analysts Assess Adaptive Biotechnologies: What You Need To Know - Benzinga
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Stock Forecast: Downside Of -42.28% By 2025 - Stocksregister
Adaptive Biotechnologies (ADPT) Price Target Raised by Morgan Stanley | ADPT Stock News - GuruFocus
Adaptive Biotechnologies (ADPT) Price Target Increased by Morgan Stanley | ADPT Stock News - GuruFocus
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Stock Position Lifted by Wells Fargo & Company MN - Defense World
Adaptive Biotechnologies Soars 120% In 9 MonthsCan The Momentum Continue? - RTTNews
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.57 - Yahoo Finance
Adaptive Biotechnologies (NASDAQ:ADPT) Sets New 1-Year High After Earnings Beat - The AM Reporter
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2025 Earnings Call Transcript - Insider Monkey
Adaptive Biotechnologies (NASDAQ:ADPT) Reaches New 12-Month High Following Earnings Beat - Defense World
Decoding Adaptive Biotechnologies Corp (ADPT): A Strategic SWOT Insight - GuruFocus
Adaptive Biotechnologies stock soars on Q1 earnings beat By Investing.com - Investing.com Canada
Adaptive Biotechnologies stock soars on Q1 earnings beat - Investing.com
Adaptive Biotechnologies Corp (ADPT) Stock: A Year of Highs and Lows in the Market - investchronicle.com
Nasdaq Surges Over 300 Points; Apple Shares Fall After Q2 Results - Benzinga
Adaptive Biotechnologies Lifts Forecasts And Sees Share Price Jump - Finimize
Adaptive Biotechnologies (ADPT): Goldman Sachs Raises Price Target | ADPT Stock News - GuruFocus
Adaptive Biotechnologies rises after quarterly sales beat - TradingView
Adaptive Biotechnologies (ADPT) Soars 34% on Strong Q1 Earnings - RagingBull
Adaptive Biotechnologies: Q1 Earnings Snapshot - marketscreener.com
Adaptive Biotechnologies Corp (ADPT) Q1 2025 Earnings Call Highlights: Strong MRD Revenue ... - Yahoo Finance
Adaptive Biotechnologies Corp (ADPT) Q1 2025 Earnings Call Highl - GuruFocus
Adaptive Biotechnologies Corp (ADPT) Q1 2025 Earnings: EPS of -$ - GuruFocus
Adaptive Biotechnologies Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Adaptive Biotechnologies (ADPT) Reports Strong Q1 2025 Earnings with Raised Guidance - GuruFocus
Adaptive Biotechnologies (ADPT) Surpasses Q1 Revenue Expectations | ADPT Stock News - GuruFocus
Earnings call transcript: Adaptive Biotechnologies beats Q1 2025 EPS forecast By Investing.com - Investing.com South Africa
Adaptive Biotechnologies Q1 2025 slides: MRD revenue jumps 34%, expenses decline - Investing.com Canada
Adaptive Biotechnologies Q1 2025 slides: MRD revenue jumps 34%, expenses decline By Investing.com - Investing.com South Africa
Adaptive Biotechnologies (ADPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Earnings call transcript: Adaptive Biotechnologies beats Q1 2025 EPS forecast - Investing.com
Adaptive Biotechnologies earnings beat by $0.09, revenue topped estimates - Investing.com
Adaptive Biotechnologies Reports First Quarter 2025 Financial Results - The Manila Times
Adaptive Biotechnologies Corp SEC 10-Q Report - TradingView
Adaptive Biotechnologies Corp (ADPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.54%
7.58%
자본화:
|
볼륨(24시간):